Project Grant R43AG094503
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $474,092 Project Grant under the Aging Research federal grant program (CFDA 93.866) to One Health Studio LLC in San Francisco, CA. The grant supports the development and evaluation of the "FLOURISH ALL" platform, an AI-enabled digital health solution aimed at reducing Alzheimer's disease and related dementia (ADRD) risk in midlife women through stress management and promotion of...
- This $399,999 project grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to further develop and test a novel, passive, and unobtrusive smartphone-based tool called SKYE for assessing cognitive function in peri- and post-menopausal women. The project has three key objectives: 1) cross-platform development of the SKYE tool, 2) testing the feasibility and usability of SKYE through focus groups, and 3) validating the SKYE cognitive score against gold-standard...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $298,883 to Iaterion, Inc. to develop a safer menopausal hormone therapy (MHT) formula that can be used long-term to treat protracted menopausal symptoms and prevent chronic diseases like osteoporosis, diabetes, obesity, and metabolic syndrome. The project aims to create an estradiol/reprogramming ligand combination that can potentially replace the progestin component of current MHT...
- The National Institute on Aging (NIA) awarded a $1,558,726 Project Grant under the Aging Research program (CFDA 93.866) to the University of Pittsburgh. The grant, titled "MENOBRAIN: A Longitudinal Investigation of Menopause and Brain Health," will conduct a 5-year study to elucidate the brain and cognitive changes that occur during the perimenopause phase of the menopause transition, and the factors contributing to these changes. The study will recruit 224 women in the late...
- The National Institute on Aging (NIA), within the U.S. Department of Health and Human Services, has awarded a $277,391 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Amira Health Inc. of Massachusetts. The purpose of this Phase I Small Business Innovation Research (SBIR) award is to validate the effectiveness of Amira's "Terra" device, a closed-loop temperature control system designed to mitigate vasomotor symptoms (hot flashes) and improve sleep...
- This $150,000 Project Grant was awarded on September 1, 2025 by the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The grant will fund the "Waning Moon" intervention, a culturally tailored health education program designed to address menopause symptoms and cardiovascular disease risk in urban American Indian/Alaska Native women. The program will provide education on conventional and complementary...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research at Iowa State University to study the relationship between the menopause transition and accelerated cerebrovascular aging in women. The $405,155 award, commencing on September 1, 2025, will support a 2-year project to determine differences in cerebral pulsatility, cerebral blood flow, and associated vascular contributors between pre-, peri-, and post-menopausal women. The research aims...
- This $625,898 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop spatially-informed, cell-specific metabolic models of the ovary to identify novel biomarkers associated with the onset and duration of the menopause transition. The key products and services to be delivered include: Generation of spatially-informed, cell-specific, multicellular genome-scale metabolic models (GMMs) of the ovary using single-cell and spatial transcriptomics data...
- This $3,377,863 Project Grant was awarded on September 15, 2025 by the National Institute on Aging (CFDA 93.866 Aging Research) to the Mayo Clinic in Minnesota. The objective is to analyze women-specific health patterns from electronic health records to address diagnostic disparities in the progression of cognitive impairment and dementia. The project aims to leverage precision medicine approaches to better understand how factors unique to women, such as menopause and pregnancy, may impact...
- This $4,765,698 federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will fund a research study by the University of California, Santa Barbara to investigate the effects of endocrine aging on spatial navigation ability and its neuronal systems. The project will enroll 240 cognitively normal midlife adults, with a balanced distribution of pre-, peri-, and post-menopausal women, and use immersive virtual environments and brain imaging to elucidate how...
This $399,813 Project Grant award from the National Institute on Aging (NIA), under the Aging Research grant program (CFDA 93.866), supports the development of WHIM (Women's Health in Menopause), a digital health product designed to improve the menopause-related experience for midlife women. The project extends an existing digital behavioral intervention platform, GEMINI, to create WHIM, which will incorporate the MENOGAP patient education program and enhance the platform with additional features to facilitate online medical group visits and self-management tools for menopausal women. The goal is to improve access to menopause care and treatments by leveraging technology-enabled solutions. The award was granted to Brightoutcome Inc., a woman-owned small disadvantaged business in Illinois that specializes in developing digital health platforms to address complex healthcare challenges.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $399.8k | 9/15/25 |